Dongin Biotech Co. Ltd agreed to acquire GTG Wellness Co., Ltd. (KOSDAQ:A219750) In reverse merger transaction on February 2, 2024. When the merger between Dongin Biotech Co.

Ltd and GTG Wellness Co., Ltd. (KOSDAQ:A219750) is completed, GTG Wellness Co., Ltd becomes the surviving corporation, and Dongin Biotech Co. Ltd becomes a extinguished corporation. Transaction is expected to complete on March 29, 2024.